• Prenatal methadone enhances METH-induced increment in locomotor activity in rats.
a b s t r a c t
It has been known that methadone maintenance treatment is the standard treatment of choice for pregnant opiate addicts. However, there are few data on newborn outcomes especially in the cross talk with other addictive agents. The present study was to investigate the effect of prenatal exposure to methadone on methamphetamine (METH)-induced behavioral sensitization as an indicator of drug addiction in later life. Pregnant rats received saline or methadone (7 mg/kg, s.c.) twice daily from E3 to E20. To induce behavioral sensitization, offspring (5 weeks old) were treated with METH (1 mg/kg, i.p.) or saline once daily for 5 consecutive days. Ninety-six hours (day 9) after the 5th treatment with METH or saline, animals received a single dose of METH (1 mg/kg, i.p.) or saline to induce the reinstated behavioral sensitization. Prenatal methadone treatment enhanced the level of development of locomotor behavioral sensitization to METH administration in adolescent rats. Prenatal methadone treatment also enhanced the reinstated locomotor behavioral sensitization in adolescent rats after the administration had ceased for 96 h. These results indicate that prenatal methadone exposure produces a persistent lesion in the dopaminergic system, as indicated by enhanced METH-induced locomotor behavioral sensitization (before drug abstinence) and reinstated locomotor behavioral sensitization (after short term drug abstinence) in adolescent rats. These findings show that prenatal methadone exposure may enhance susceptibility to the development of drug addiction in later life. This could provide a reference for drug usage such as methamphetamine in their offspring of pregnant woman who are treating with methadone.
© 2013 The Authors. Published by Elsevier B.V.
Introduction
Methadone, a synthetic opioid, was developed in Germany in 1937, and it is first used to replace morphine for pain treatment. It usually comes in liquid form, which the patient drinks for the treatment of chronic pain [1] . Recently, methadone is used to treat for opiate addiction, and it currently remains the standard treatment for opiate addiction in pregnancy [2] . Evidence shows that chronic use of methadone causes addictive liability and respiratory depression in some subjects [3] . It has been reported that maternal methadone dosage is associated with neonatal abstinence syndrome score on the percentage of treatment for withdrawal and the duration of neonatal hospitalization [4] . These findings indicate that methadone in high doses would not be a good therapeutic agent for pregnant women. However, it is unclear that the effect of prenatal exposure to methadone on the central nervous system or cross interaction with other addictive drugs such as methamphetamine in later life.
Methamphetamine is a very addictive stimulant drug that activates certain systems in the brain. It is a member of amphetamine family, but the effects of methamphetamine are much more potent, longer lasting, and more harmful to the central nervous system [5] . It has been reported that repeated administration of methamphetamine produces a progressively enhanced and persistent behavioral response in rodents, a phenomenon called "behavioral sensitization" [6, 7] . Behavioral sensitization is considered to be related to compulsive drug-seeking behavior [8] . Previous studies have indicated that once sensitization has developed, a challenge dose of methamphetamine exhibits behavioral hyperactivity (reinstatement of drug seeking behavior), characterized by increase in locomotor activity and stereotyped behaviors in animals [9] [10] [11] . Although the mechanism responsible for methamphetamineinduced behavioral sensitization remains unclear, it is believed that the mesolimbic dopaminergic system in the central nervous system plays a critical role in the development of behavioral sensitization [12, 13] .
Topographic overlaps between opioid and dopamine neurons are found in the central nervous system, suggesting that interactions exist between these two systems [14] . Previous studies have demonstrated that opioid systems are the targets for psychostimulants as well. For example, the opioid receptor antagonist naltrexone can attenuate methamphetamine-induced locomotor activity in mice [15] and the mu-opioid receptor knockout mice show insensitive to methamphetamine-induced behavioral sensitization [9, 16] . The last decade, methadone maintenance treatment becomes the standard treatment of choice for pregnant opiate addicts [17, 18] . Therefore, the effect of the earlier exposure to methadone on the central nervous system or the biochemical changes induced by other addictive agents should be respected.
The objective of this study was to determine whether the prenatal methadone treatment leads to a long-lasting change in the brain rewarding system which can enhance adolescent susceptibility to the development of addictive-like behavior in adolescent rats. The current results may represent a useful approach to study the interactions between prenatal methadone treatment and the development of drug addiction in later life, as well as the mechanisms involved.
Methods

Animals
Timed pregnant Sprague-Dawley rats (BioLASCO Taiwan Co., Ltd) arrived in the laboratory on day 2 of gestation (E2). Animals were maintained in a room with a 12 h light/dark cycle and at constant temperature (25 • C). All procedures for animal care were approved by the Institutional Animal Care and Use Committee of National Health Research Institutes or Fu Jen Catholic University at Taiwan. Every effort was made to minimize the number of animals used and their suffering.
Prenatal treatment
Pregnant Sprague-Dawley rats received methadone (7 mg/kg) by subcutaneous (s.c.) injection twice daily (9:00 and 17:00) from gestation E3 to E20. The control rats were injected with the same volume of sterile saline (1 ml/kg of body weight). The day of birth was defined as postnatal day 0 (P0). The offspring were weaned at P21 and four rats (2 prenatal methadone-treated and 2 prenatal saline-treated) per cage were housed after weaning. Sixteen rats from eight dams for each group were used in the present study.
Drug administration
Sixteen rats from the prenatal methadone or saline-treated group were further divided into two groups: one received 5 doses of the intraperitoneal (i.p.) injection of methamphetamine hydrochloride (METH; Taiwanese Food and Drug Administration, Taiwan, ROC) (1 mg/kg) (eight rats) and the other with saline (eight rats) on P35. METH was freshly dissolved in physiological saline before use.
Animals began a treatment schedule of 5 daily injections of METH (1 mg/kg, i.p.) to induce behavioral sensitization from day 1 (P35) to day 5 (P39). To reintroduce behavioral sensitization after short-term period of drug abstinence, animals received a single dose of 1 mg/kg METH (i.p.) on day 9 (P43, four days after repeated injection of METH) (Fig. 1 ).
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Measurement of locomotor activity
METH-induced locomotor behaviors were performed as previously described [11] with modifications. In brief, the locomotor activity of rats were monitored in the plexiglas box (30 × 30 × 50 cm; L × W × H) with a CCD camera for recording in the same order. On the experimental day, rats were transferred to acclimatize to the testing room for 60 min undisturbed, with food and water. Baseline levels of locomotion were determined during the 10 min prior to METH or saline administration (−10 to 0 min). After rats received saline or METH (1 mg/kg, s.c.), their activities were recorded for 120 min. The total distance traveled by the animal was determined during every 10-min testing period for 120 min.
Data were quantified by a computer-operated video tracking system (TopScan software, Clever System, Inc., Reston, VA, USA). The room darkness was adjusted at 100-120 lx by luminescent meter.
Data analysis and statistics
The behavioral data were presented as the mean ± SEM and analyzed by two-way repeated measures ANOVA for data from tests conducted continuously at different experimental times or days or by two-way ANOVA for the behavioral response in specific time intervals on experimental day followed by Student-Newman-Keuls test. Results with a p < 0.05 were considered statistically significant.
The alteration in the behavioral sensitization (day 5) and reinstated behavioral sensitization (day 9) to METH following prenatal methadone exposure in rats were calculated as follows, The data for the increment of distance traveled were presented as the mean ± SEM and analyzed by Student's t-test. Results with a p < 0.05 were considered statistically significant. Fig. 2A shows the total distance traveled by the rats after a single dose injection of METH immediately which was determined during every 10 min testing period for 120 min. After a single dose injection of METH in the adolescent rats (P35), both groups including prenatal exposure to saline or methadone showed increased total distance traveled from 10 min to 100 min, and from 10 min to 120 min, respectively [F(3, 252) = 172.631, p < 0.001] (p < 0.05) (Fig. 2A) . Two-way ANOVA on behavioral data (summation for 120 min) following the METH challenge showed that adolescent (P35) METH treatment and the interaction of prenatal (E3-E20) methadone treatment × adolescent (P35) METH treatment have significant effects on the total distance traveled [F(1, 28) = 354.549, p < 0.001; F(1, 28) = 5.590, p = 0.025, respectively]. Prenatal methadone exposure enhanced METH (1 mg/kg, s.c.)-induced locomotor behavioral response in P35 rats (p < 0.05) (Fig. 2B) .
Results
Prenatal administration of methadone enhanced methamphetamine-induced locomotor behavioral response in adolescent rats
Prenatal administration of methadone enhanced locomotor behavioral sensitization induced by methamphetamine in adolescent rat
Repeated administration of METH produced progressively increased behavioral response in rats. analyzed by two-way repeated measures ANOVA for data from tests conducted continuously at different experimental times or by two-way ANOVA for the behavioral response in the specific time intervals followed by Student-Newman-Keuls test. *p < 0.05 represents significant difference for the saline + METH group as compared with that of the saline + saline group. # p < 0.05 represents significant difference for the methadone + METH group as compared with that of the methadone + saline group. & p < 0.05 represents significant difference for the methadone + METH group as compared with that of the saline + METH group. distance traveled by the rats after five doses injection of METH which was determined during every 10 min testing period for 120 min. After five doses injection of METH in the adolescent rats (P39), both groups including prenatal exposure to saline or methadone showed increased total distance traveled from 10 min to 120 [F(3, 252) = 206.191, p < 0.001] (p < 0.05) (Fig. 3A) . Two-way ANOVA on behavioral data (summation for 120 min) following the METH challenge showed that adolescent (P39) METH treatment and the interaction of prenatal methadone treatment x adolescent (P39) METH treatment have significant effects on the total distance traveled [F(1, 28) = 458.167, p < 0.001; F(1, 28) = 5.413, p = 0.027, respectively]. Prenatal methadone exposure enhanced METH (1 mg/kg, s.c.)-induced locomotor behavioral response in P39 rats (p < 0.05) (Fig. 3B) .
The METH-induced behavioral sensitization occurred on day 5 showed significant greater than that of the results on day 1 (P35) in control rats (Fig. 4) . Prenatal exposed to methadone showed that the METH induced behavioral sensitization in the total distance traveled occurred two day earlier (day 3, P37) than that of the control group (day 5, P39) [F(15, 140) = 4.939, p < 0.001] (p < 0.05). analyzed by two-way repeated measures ANOVA for data from tests conducted continuously at different experimental times or by two-way ANOVA for the behavioral response in the specific time intervals followed by Student-Newman-Keuls test. *p < 0.05 represents significant difference for the saline + METH group as compared with that of the saline + saline group. # p < 0.05 represents significant difference for the methadone + METH group as compared with that of the methadone + saline group. & p < 0.05 represents significant difference for the methadone + METH group as compared with that of the saline + METH group.
Prenatal administration of methadone enhanced methamphetamine-induced reinstated locomotor behavioral sensitization in adolescent rats
To test whether repeated METH administration produced a long-lasting locomotor sensitization, animals received a single dose of METH (1 mg/kg, i.p.) or saline on P43 (day 9) 96 h after the 5th treatment with METH or saline (day 5, P39). Both prenatal saline and methadone-treated groups showed increased response to METH challenge on day 9 (P43) as compared with the response to METH on day 5 (P39) (p < 0.05) (Fig. 4) . Prenatal methadone exposure also enhanced the reinstated behavioral sensitization in rats after administration had ceased for 96 h (p < 0.05) (Fig. 4) . However, prenatal methadone exposure induced alteration in the behavioral sensitization (day 5) and reinstated behavioral sensitization (day 9) of total distance to METH administration that appears to be greater as compared with that of control rats (Fig. 4) . . 4 . Effect of prenatal methadone exposure on METH-induced behaviors sensitization (from P35 to P39) and reinstated behavioral sensitization (P43), as determined by the total distance traveled in the open field test in the male adolescent rats. Repeated administration of METH in rats developed behavioral sensitization as indicated by the progressively increased behavioral response of the total distance traveled as compared with the data of day 1 (P35). After five injections from P35 to P39 (day 1 to day 5), animals received a single injection of saline or METH after 96 h drug abstinence from the 5th injection of METH to assess the reinstated behavioral sensitization (P43, day 9). Each bar represents the cumulative distance (cm) traveled for a total duration of 120 min on the different experimental day. Bar graphs represent the alteration in the behavioral sensitization (day 5) and reinstated behavioral sensitization (day 9) to METH following prenatal methadone exposure in rats. The results are expressed as the mean ± SEM of eight animals in each group (N = 8) and analyzed by two-way repeated measures ANOVA for data from tests conducted continuously at different experimental day followed by Student-Newman-Keuls test or by Student's t-test for the alteration in the behavioral sensitization (day 5) and reinstated behavioral sensitization (day 9) to METH administration. *p < 0.05 represents significant difference for the experimental day as compared with the data of day 1 in the saline + METH group. $ p < 0.05 represents significant difference for the day 9 as compared with the data of day 5 in the saline + METH group. # p < 0.05 represents significant difference for the experimental day as compared with the data of day 1 in the methadone + METH group. % p < 0.05 represents significant difference for the day 9 as compared with the data of day 5 in the methadone + METH group. & p < 0.05 represents significant difference for the methadone + METH group as compared with that of the saline + METH group in the same experimental day. @ p < 0.05 represents significant difference for the methadone + METH group as compared with that of the saline + METH group in the alteration in the behavioral sensitization (day 5) and reinstated behavioral sensitization (day 9).
Discussion
Methadone-maintenance is a gold standard in the management of opiate-dependent pregnant women [2, 19] . However, studies both in humans and in animal models have found a variety of shortand long-term neurobehavioral consequences associated with prenatal methadone exposure [20, 21] . It has been reported that human infants born to methadone-treated mothers exhibit abstinence symptoms [22] . Animals prenatally exposed to methadone produced physical dependence [20] and developed tolerance to morphine faster than that of the control rats [23] . The present data reveal that prenatal methadone exposure enhances not only the development of locomotor behavioral sensitization induced by METH but also the reinstated behavioral sensitization in adolescent rats. These findings indicate that prenatal methadone exposure produces a persistent lesion in the rewarding system which may enhance susceptibility to the development of drug addiction in later life.
Lesions of the dopaminergic system, such as dysregulation of presynaptic striatal dopamine, alteration in central dopamine turnover, or dopaminergic receptor sensitization, were evidenced by enhanced behavioral reaction after METH administration in the animals [24, 25] . Behavioral sensitization is the progressive increase in behavioral responses following repeated treatments of a drug, and is mediated by long-lasting changes in the neural substrates mediating reward and motivation, the mesolimbic dopamine system, consisting of reciprocal projections between the ventral tegmental area and the nucleus accumbens [12, 13] . Thus behavioral sensitization resulted from neuroadaptations within the mesolimbic dopamine system caused by repeated drug exposure can be used as an indicator of drug addiction [12, 13] . Therefore, the present results of enhanced behavioral sensitization and reinstated behavioral sensitization to METH indicate that exposure to methadone in the early developing brain may induce longlasting dopaminergic injury in later life. It has been reported that perinatal methadone exposure affects dopamine, norepinephrine, and serotonin in the P21 rat brain [26] . The perinatal methadone exposure also affects the cholinergic development in rat striatum, and that may involve changes in the expression of nerve growth factor [21, 27] . Animal studies have demonstrated that the reduced striatal nerve growth factor following perinatal methadone exposure may lead to delays in the development of nervous system [21, 28] . The rat dopaminergic system develops prenatally with dopaminergic neuron birth, specification and migration to their final position [29] . Thus, it is likely that prenatal methadone exposure might impair the development of dopaminergic system.
Moreover, topographic overlaps between opioid receptor system and dopaminergic neuron are found in the central nervous system, suggesting that interactions exist between these two systems [14] . Previous studies indicate that the opioid receptor antagonist naltrexone can attenuate methamphetamine-induced locomotor activity in mice [15] and the mu-opioid receptor knockout mice show insensitive to methamphetamine-induced behavioral sensitization [9, 16] . Therefore, another possible mechanism for the altered dopaminergic system may cause by the interaction with the affected opioid system following the prenatal methadone exposure. Besides, the altered white matter development has been found in children born to methadone-maintained mothers [19] . Prenatal exposure to opioids impairs myelination [30] and synaptic plasticity in the developing rat brain [31] . The prenatal opioid-induced alteration of myelination may contribute to the dysfunction of nervous system, such as dopaminergic system. However, the further study is needed.
The current findings suggest that prenatal methadone exposure may have effects on the dopaminergic system mediating behavioral sensitization, and may enhance susceptibility to the development of drug addiction in later life. Since methadone-maintenance remains the recommended treatment option for opiate-addicted pregnant women, the detailed mechanisms involved in prenatal methadone exposure-induced enhancing susceptibility to the development of drug addiction in later life need to be further investigated.
